Another study found that GnRH analogs increased the mean ovarian volume (MOV) in HH and idiopathic precocious puberty (IPP) patients, but did not affect incidence of oligomenorrhea, obesity or neurological disorders (39). The gene discussed is GNRH1; the disease is obesity due to melanocortin 4 receptor deficiency.